Mainstay Medical

Irish back pain group Mainstay Medical raises €115m to fund expansion

Two new investors lead funding round as company looks to accelerate commercial rollout in key US market as well as Europe and Australia

Mon Feb 26 2024 - 21:30

Back pain device group Mainstay Medical raises $108m

Funding will drive commercialisation of Reactiv8 in critical US market

Tue Feb 16 2021 - 18:24

Fountain closes third life sciences fund after raising €125m

Group eyeing up to 10 investments, mostly in therapeutics and medical device sectors

Tue Nov 03 2020 - 11:53

Mainstay Medical gets approval to sell back pain device in US

Company secures FDA approval for its flagship medical device called ReActiv8

Mon Jun 22 2020 - 08:18

Irish back pain medical device group receives important approval in Australia

Mainstay Medical’s flagship product is now eligible for reimbursement from private health funds

Mon Jun 08 2020 - 07:40

Irish back pain medical device group to pull stock market listings

Mainstay Medical cites poor liquidity in shares and cost for decision to take business private

Tue Apr 07 2020 - 17:32

Mainstay Medical pares losses by over one-third in 2019

Revenue at Irish medical device company targeting chronic back pain almost doubles

Tue Feb 25 2020 - 11:14

Hope for US-China trade deal cheers markets

Holiday week sees thin trading in Dublin as rise in online shopping boosts Amazon

Fri Dec 27 2019 - 18:38

Mainstay meets with FDA on ReActiv8 application

‘Day 100’ meeting reviews status of application’s review

Thu Dec 12 2019 - 07:46

Mainstay Medical doubles revenue in first six months

Company submits application for pre-market approval to US regulator

Fri Sept 20 2019 - 19:53

Irish VC group Fountain Healthcare Partners raises €118m

Group beats €100m target and intends to invest the bulk of the fund in Europe and US

Thu May 23 2019 - 20:21

Shares crash as Mainstay back pain device fails clinical trial

Company insists other data support case for its implanted electrical stimulation device

Mon Nov 19 2018 - 12:27

Mainstay on track to announce trial results as revenues rise

Company awaits data as it looks to roll-out ReActive8 device to patients in the US

Fri Sept 21 2018 - 09:06

Irish tech firms see VC funding fall for first time since 2011

Call for Government action after funding falls 9% to €453m in first six months of 2018

Thu Sept 20 2018 - 05:55

Mainstay Medical appoints new chief financial officer

Matthew Onaitis joins medical device company from Cidara Therapeutics

Mon Aug 20 2018 - 08:27

Mainstay Medical hits milestone in key US clinical trial

Group completes back pain neurostimulator implants in all 204 patients enrolled in test for device

Tue Jul 10 2018 - 17:42

Mainstay hits delay in Australian approval for ReActiv8

Company will wait until end of US trial on back pain therapy for new clinical data requested by authorities

Thu Apr 05 2018 - 09:23

Mainstay Medical raises €30m from new share placing

Company says five centres in Germany and Ireland have implanted patients with ReActiv8

Thu Feb 15 2018 - 16:37

Mainstay Medical passes ‘important milestone’ in clinical trials

Firm aims to bring its new therapy for chronic lower back pain to key US market

Mon Dec 11 2017 - 19:55

Mainstay Medical losses increase by 50%

Irish company positive about clinical trial stemming from its ReActiv8-B product

Tue Sept 05 2017 - 19:09

Mainstay Medical to seek further funding as full-year losses mount

Dublin-listed medical devices firm recently made its first commercial sale in Germany

Thu Aug 24 2017 - 18:12

The major business events happening this week

For Your Diary: INM results, UK retail figures and Girls in Tech conference

Mon Mar 20 2017 - 11:19

Mainstay Medical sells its first ReActiv8 implant for back pain

Iseq-listed medical device firm targets commercial growth and completion of US clinical trials

Wed Feb 01 2017 - 19:49

Mainstay Medical seeks approval to sell ReActiv8 in Australia

Dublin-listed firm pushes ahead with plans to commercialise back pain treatment

Thu Jan 12 2017 - 07:49

Irish tech firms raise €734m in first nine months of 2016

Survey shows level of investment in Irish tech companies has risen sharply in recent years

Thu Nov 10 2016 - 01:00

Mainstay Medical adds eighth US patent to its IP portfolio

Company’s flagship product ReActiv8 won European approval earlier this year

Wed Oct 26 2016 - 08:12

Irish-headquartered Mainstay posts first-half loss of $8m

Mainstay raised €30m funding in June through placing of new shares

Thu Sept 22 2016 - 18:15

Irish-headquartered Mainstay sees losses narrow to $13m

Operating expenses also decline while R&D and clinical and regulatory costs rise

Tue Aug 16 2016 - 05:45

Buzz builds as Dublin hosts Innovation in Medtech conference

Venture capital firms with more than €13bn in funds will seek investment opportunities

Mon Apr 11 2016 - 06:30

Mainstay Medical sees drop in full-year operating expenses

Dublin-listed medical devices firm says plans progressing to bring ReActiv8 to market

Mon Feb 08 2016 - 08:21

Mainstay posts encouraging trial results

New approach to alleviating chronic back pain

Thu Sept 03 2015 - 01:00

Mainstay Medical to seek European approval for device

A trial of 47 patients showed after three months, 63 per cent reported clinically important improvement in back pain

Mon Aug 31 2015 - 21:40

Irish medical firm Mainstay receives third US patent

Dublin-listed company pushing forward with plans to bring Reactiv8 to market

Wed Aug 26 2015 - 09:13

Mainstay Medical agrees debt facility of up to $15m

Company will use money to build momentum towards commercialisation of ReActiv8

Mon Aug 24 2015 - 08:21